Skip to search formSkip to main contentSkip to account menu

teloxantrone

Known as: Anthra(1,9-cd)pyrazol-6(2H)-one, 7,10-dihydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)-5-((2-(methylamino)ethyl)amino)-, Anthra(1,9-cd)pyrazol-6(2H)-one,7,10-dihydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)-5-((2-(methylamino)ethyl)amino)-, Moxantrazole 
An anthrapyrazole antineoplastic antibiotic. Teloxantrone intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA… 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

AnthraquinonesPyrazoles

Narrower (2)

CI 937Dup 937

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
Phase II study on DuP 937 (Teloxantrone) in colorectal carcinoma
DuP 937 (Teloxantrone) is a new anthrapyrazole intercalator that inhibits DNA synthesis. Experimental antitumor activity was… 
1993
1993
A phase II trial of DuP 937 (Teloxantrone) in non-small cell lung cancer. A study of the NCIC Clinical Trials Group.
1993
1993
A phase II study of DuP 937 (Teloxantrone) in metastatic malignant melanoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCICCTG).
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)